News & Blog

Tag Archives: FDA

One Last Look: Outcomes & Advancements in 2015

Before we completely put 2015 in the rearview, we’d be remiss if we didn’t give a quick review of the progress and impact that we made, together, last year. (Note: NBTS will have a more comprehensive Annual Report later in the year). We’ve already taken a look back at some of our staff’s favorite memories […]

Congress Delivers Brain Tumor Community Holiday Gift

More funding for NIH to raise all ships, and specific funding for pediatric brain tumors, is welcome! More money will be available for brain tumor research in 2016, thanks to a year-end budget deal in the United States Congress that was reached today. The “omnibus” spending bill that sets government spending levels and priorities for […]

Survey Results: Clinical Trial Participation

  National Brain Tumor Society, in conjunction with neuro-oncologists, scientific researchers, and the biopharmaceutical industry, is constantly looking for new and better treatments for patients. However, scientific progress in a laboratory does not necessarily always lead to new treatments for patients. First, those laboratory results need to be evaluated and confirmed in high quality clinical trials to ensure […]

Share